![N-[3-tert-Butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]-N'-[2-fluoro-4-[(2-(methylcarbamoyl)pyridin-4-yl)oxy]phenyl]urea structure, CAS 1020172-07-9](/structures/180000/171117_2_1020172_07_9.png)
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 1020172-07-9 |
| Catalog No. | 2A-1170935 |
| Chinese Name | N-[3-叔丁基-1-(喹啉-6-基)-1H-吡唑-5-基]-N'-[2-氟-4-[(2-(甲基氨基甲酰基)吡啶-4-基)氧]苯基]脲 |
| Synonyms | DCC2036; Rebastinib; Rebastinib [USAN]; DP-1919; DCC-2036 |
| Molecular Formula | C30H28FN7O3 |
| Molecular Weight | 553.587 |
| Purity | 98% |
| Density | 1.3±0.1 g/cm3 |
| Boiling Point | 666.8±55.0 °C at 760 mmHg |
| Appearance | White to off-white solid |
| Storage Condition | -20℃ |
| Application | Rebastinib (DCC-2036) is a Bcr-Abl inhibitor inhibitor, acting on Abl1WT and Abl1T315I, with IC50 of 0.8 nM and 4 nM respectively. It also inhibits SRC, KDR, FLT3 and Tie-2, and has low activity on c- |
| PubChem ID | 56403339 |
| SMILES | CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1 |
| InChI | InChI=1S/C30H28FN7O3/c1-30(2,3)26-17-27(38(37-26)19-7-9-23-18(14-19)6-5-12-33-23)36-29(40)35-24-10-8-20(15-22(24)31)41-21-11-13-34-25(16-21)28(39)32-4/h5-17H,1-4H3,(H,32,39)(H2,35,36,40) |
| InChI Key | WVXNSAVVKYZVOE-UHFFFAOYSA-N |
| Transport Info | Product name: DCC-2036 (Rebastinib) |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| Potassium cyclohexene-1-trifluoroborate | 1186667-20-8 | 2A-1170928 |
| EX-527 (R-enantioMer) | 848193-69-1 | 2A-1170930 |
| EX527 | 848193-68-0 | 2A-1170931 |
| Octanoic acid, 6,8-bis[(phenylMethyl)thio]- | 95809-78-2 | 2A-1170932 |
| Golvatinib (E7050) | 928037-13-2 | 2A-1170933 |
| PD0332991 Isethionate | 827022-33-3 | 2A-1170936 |
| LY2835219 | 1231930-82-7 | 2A-1170938 |
| SU 5416 | 204005-46-9 | 2A-1170940 |
| LEE011 | 1211441-98-3 | 2A-1170941 |
| ON-01910 | 1225497-78-8 | 2A-1170942 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA